2/5/2019 12:28:02 PM - Reported earnings +32% on +3% sales revenues for the Dec &#39;18 quarter. Showed earnings increases above the +25% minimum guideline (C criteria) in the 4 latest quarterly comparisons. Sub par sales revenues growth and limited history is a concern. Completed its $17 IPO on 1/12/18.&quot;<br><hr>11/13/2018 12:57:23 PM - Sputtering after a gap down violating its 50 DMA line with a damaging loss marked by above average volume. Last noted in the 11/07/18 mid-day report with caution - <i>&quot;Reported earnings +48% on +3% sales revenues for the Sep &#39;18 quarter. Showed earnings increases above the +25% minimum guideline (C criteria) in the 3 latest quarterly comparisons through Sep &#39;18. Sub par sales revenues growth and limited history is a concern. Completed its $17 IPO on 1/12/18.&quot;</i><br><hr>11/7/2018 1:18:32 PM - Gapped down on the prior session violating its 50 DMA line with a damaging loss marked by above average volume. Reported earnings +48% on +3% sales revenues for the Sep &#39;18 quarter. Showed earnings increases above the +25% minimum guideline (C criteria) in the 3 latest quarterly comparisons through Sep &#39;18. Sub par sales revenues growth and limited history is a concern. Completed its $17 IPO on 1/12/18.<br><hr>11/6/2018 1:06:04 PM - Reported earnings +48% on +3% sales revenues for the Sep &#39;18 quarter. Gapped down today violating its 50 DMA line with a damaging loss marked by above average volume.  Showed earnings increases above the +25% minimum guideline (C criteria) in the 3 latest quarterly comparisons through Sep &#39;18. Sub par sales revenues growth and limited history is a concern. Completed its $17 IPO on 1/12/18.<br><hr>10/2/2018 12:38:34 PM - Perched at its 52-week and all-time high following a streak of 8 consecutive gains marked by volume.  Showed earnings increases above the +25% minimum guideline (C criteria) in the 2 latest quarterly comparisons through Jun &#39;18.  Limited history is a concern. Completed its $17 IPO on 1/12/18.<br><hr>